Rheumatology Informatics System for Effectiveness (RISE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02230943|
Recruitment Status : Unknown
Verified August 2014 by American College of Rheumatology.
Recruitment status was: Recruiting
First Posted : September 3, 2014
Last Update Posted : September 3, 2014
The RISE Registry is an enhanced version of the ACR's Rheumatology Clinical Registry (RCR) and allows for a simplified entry process, while establishing a best-in-class resource to manage your patient population and improve patient care.
RISE provides participants with an infrastructure for robust quality improvement activities leading to improved patient outcomes, patient population management and quality reporting related to rheumatic diseases and drug safety. RISE gives physicians and researchers the information they need to optimize patient outcomes, meet reporting requirements, and make discoveries that advance rheumatology.
|Condition or disease|
|Rheumatoid Arthritis Osteoarthritis Gout|
RISE helps providers benchmark performances on key rheumatology clinical quality measures and align with best practice standards. The RISE benchmarking tool allows providers to view the details of their patient population against established rheumatology quality metrics. RISE allows access to aggregate data from other participating sites so providers can view their patient population in comparison to other RISE participants.
RISE is integrated into an electronic health records (EHR) system, bringing a single point of entry into one solution for filing for quality-based incentive payments, avoiding penalties, complying with reporting requirements and tracking caseloads for quality monitoring and improvement initiatives. RISE collects the data needed to meet current federal reporting requirements.
Participating in RISE helps push the field of rheumatology practice forward. RISE provides a source of information on patient outcomes and quality care for rheumatology leading to new discoveries, better understanding and a source of comparative effectiveness research.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||100000 participants|
|Target Follow-Up Duration:||1 Year|
|Official Title:||American College of Rheumatology's Rheumatology Informatics System for Effectiveness|
|Study Start Date :||April 2014|
|Estimated Primary Completion Date :||December 2015|
- Controlling High Blood Pressure [ Time Frame: one year ]Percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (<140/90mmHg) during the measurement period.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02230943
|Contact: Melissa D Francisco||404-633-3777 ext email@example.com|
|Contact: Rachel Myslinski, MBA||404-633-3777 ext firstname.lastname@example.org|
|United States, Georgia|
|American College of Rheumatology||Recruiting|
|Atlanta, Georgia, United States, 30319|
|Contact: Melissa D. Francisco 404-633-3777 ext 102 email@example.com|